Reata Pharmaceuticals Inc buy melinda
Start price
21.10.17
/
50%
?32.73
Target price
06.12.17
€35.00
Performance (%)
-30.35%
End price
06.12.17
€22.80
Summary
This prediction ended on 06.12.17 with a price of €22.80. Massive losses of -30.35% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Reata Pharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | -1,34 % | -5,62 % | 3,38 % | 51,20 % |
| iShares Nasdaq 100 | -1,07 % | 2,60 % | 19,13 % | 93,73 % |
| iShares Nikkei 225® | -1,99 % | -6,51 % | 27,85 % | 51,19 % |
| iShares S&P 500 | -1,32 % | 0,91 % | 14,19 % | 65,29 % |
Comments by melinda for this prediction
In the thread Reata Pharmaceuticals Inc diskutieren
Reata Pharmaceuticals, Inc.
Reata kündigt Ende der Präsentation der wichtigsten Ergebnisse der Phase - 2 - Studie KARDINAL während der 2017 Jahrestagung der American Society of Nephrology
(Vom Mitglied beendet)
Stopped prediction by melinda for Reata Pharmaceuticals Inc
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?84.56
03.04.19
03.04.19
€92.00
04.11.19
04.11.19
0.00%
04.11.19
04.11.19
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?88.32
27.02.19
27.02.19
€90.20
04.03.19
04.03.19
2.32%
04.03.19
04.03.19
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?59.89
23.07.18
23.07.18
€63.14
25.07.18
25.07.18
12.39%
25.07.18
25.07.18
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?29.52
21.10.17
21.10.17
€31.57
06.12.17
06.12.17
-30.35%
06.12.17
06.12.17